- Home
- APLS vs MLCO Comparison
APLS vs MLCO Comparison
Compare APLS & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- MLCO
- Stock Information
- Founded
- APLS 2009
- MLCO 2004
- Country
- APLS United States
- MLCO Hong Kong
- Employees
- APLS N/A
- MLCO N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- MLCO Hotels/Resorts
- Sector
- APLS Health Care
- MLCO Consumer Discretionary
- Exchange
- APLS Nasdaq
- MLCO Nasdaq
- Market Cap
- APLS 3.5B
- MLCO 3.7B
- IPO Year
- APLS 2017
- MLCO 2006
- Fundamental
- Price
- APLS $23.80
- MLCO $8.43
- Analyst Decision
- APLS Buy
- MLCO Buy
- Analyst Count
- APLS 20
- MLCO 6
- Target Price
- APLS $33.47
- MLCO $9.78
- AVG Volume (30 Days)
- APLS 2.3M
- MLCO 2.5M
- Earning Date
- APLS 11-04-2025
- MLCO 11-04-2025
- Dividend Yield
- APLS N/A
- MLCO N/A
- EPS Growth
- APLS N/A
- MLCO N/A
- EPS
- APLS N/A
- MLCO 0.14
- Revenue
- APLS $754,649,000.00
- MLCO $4,926,670,000.00
- Revenue This Year
- APLS $22.11
- MLCO $12.85
- Revenue Next Year
- APLS N/A
- MLCO $3.61
- P/E Ratio
- APLS N/A
- MLCO $61.78
- Revenue Growth
- APLS 20.02
- MLCO 12.41
- 52 Week Low
- APLS $16.10
- MLCO $4.55
- 52 Week High
- APLS $35.72
- MLCO $10.15
- Technical
- Relative Strength Index (RSI)
- APLS 47.98
- MLCO 32.00
- Support Level
- APLS $21.07
- MLCO $9.14
- Resistance Level
- APLS $23.50
- MLCO $9.67
- Average True Range (ATR)
- APLS 0.80
- MLCO 0.30
- MACD
- APLS -0.03
- MLCO -0.14
- Stochastic Oscillator
- APLS 78.45
- MLCO 10.37
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts and Entertainment Ltd is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao with the rest largely from the Philippines as of 2024.